University Hospital of North Norway
Tromsø, 9038, Norway
NCT Number: NCT01395290
There are indications that the vitamin D status of an individual is related to susceptibility to staphylococcal infections. In the present study we will examine nasal colonisation rate in subjects participating in an ongoing vitamin D intervention study ( 20.000 IU cholecalciferol per week vs placebo) for the prevention of type 2 diabetes in subjects with impaired glucose tolerance.
Looking for future studies?
Notify Me20 year–85 year
All sexes
Interventional
Phase 3
Tromsø, 9038, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
20.000 IU per week, oral
Time frame: 6 months
University of Tromso
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01431326
Adenoviridae Infections, Adenovirus
Anchorage, Alaska, United States
View Trial DetailsNCT03262558
Bacterial Infections, Bacterial Infections and Mycoses
Rennes, France
View Trial DetailsNCT01321879
Bacteremia, Bacterial Infections
Houston, Texas, United States
View Trial DetailsNCT01551667
Bacteremia, Bacterial Infections
Nîmes, Gard, France
View Trial Details